ABL Bio Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 641.61 million compared to negative sales of KRW 0.00047 million a year ago. Net income was KRW 24,334.61 million compared to net loss of KRW 8,557.39 million a year ago.

Basic earnings per share from continuing operations was KRW 509 compared to basic loss per share from continuing operations of KRW 181 a year ago. Basic earnings per share was KRW 509 compared to basic loss per share of KRW 181 a year ago.